Qiulu Zhou
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.
TREM2 signaling in Parkinson's disease: Regulation of microglial function and α-synuclein pathology.
Journal: International immunopharmacology
Published: July 31, 2024
Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
Journal: CNS neuroscience & therapeutics
Published: May 07, 2023
Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease.
Journal: Neurobiology of disease
Published: May 03, 2023
Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis.
Journal: CNS neuroscience & therapeutics
Published: May 16, 2022
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
Journal: Journal of neuroinflammation
Published: November 20, 2021
Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson's Disease?
Journal: Molecular neurobiology
Published: June 03, 2021
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
Journal: Frontiers in immunology
Published: June 03, 2021
Calcitriol Alleviates MPP+- and MPTP-Induced Parthanatos Through the VDR/PARP1 Pathway in the Model of Parkinson's Disease.
Journal: Frontiers in aging neuroscience
Published: January 22, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026